Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.
October 21, 2013
MINNEAPOLISAmla fuit, also known as Indian gooseberry has been shown to act as an anticoagulant and anti-inflammatory agent, according to research published in the British Journal of Nutrition.
The fruit contains more antioxidant activity than blueberries, 20 times more vitamin C than lemon juice, 30 times more polyphenols than red wine and more gallic acid than any other fruit.
For centuries, amla has been used in traditional Ayurvedic formulations for the prevention and treatment of many inflammatory diseases. SunAmla powder, a proprietary amla extract, Japanese researchers put this property to the test by evaluating its effect on human endothelial cells and in a rat model. In both cases, they found that amla fruit extract significantly inhibited the biological responses that can lead to inflammation and blood clots.
SunAmla is a highly bioavailable formulation designed to facilitate delivery of the amlas unique complex of components, such as polyphenols, which work to combat the free radicals and contribute to overall better health. SunAmla powder, produced by water extraction, is gluten-free, non-GMO, and is suitable for use in dietary supplements, nutritional bars, powder drink mixes, cereals, jams, yogurt and even ice cream.
Taiyo International, the company behind the development of the SunAmla product family, is supporting the Ayurvedic tradition of the Indian gooseberry with the development of consumer education and awareness programs. These programs are designed to increase the publics understanding of the nutritional benefits of whole food sources of superfruits that are rich in nutrients and antioxidants. The SunAmla education and awareness program aims to support and build on this current momentum as part of Taiyos mission to provide Americas health seekers with a ready abundance of information on amla.
You May Also Like
Here's why creatine sales are surging this past yearFeb 21, 2024
DSHEA's 25th anniversary: Industry vets, critics respondFeb 21, 2024
The Month in 2: Sports – videoFeb 21, 2024
Tianeptine sales spur another FDA warning, action by state lawmakersFeb 20, 2024